Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

The Trump administration has revoked several Biden-era health directives in a flurry of late night activity March 14. | President Trump took another step in dismantling Biden's health policy legacy by ...

Officials at the National Institutes of Health (NIH) have reportedly told scientists to scrub all references to mRNA vaccine ...

According to a Russian military blogger, mass use of fiber optic FPV drones to target Ukrainian logistics forced them to ...

The pandemic stretched us—our communication, our science, our distribution networks, even what it means to be a good citizen ...

SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

This week marks a somber anniversary: five years since New York shut down as a deadly virus was ravaging the state, the ...

Five years after the COVID-19 pandemic began, we are less prepared for another outbreak, scientists say is inevitable in an ...

President Donald Trump has invoked a centuries-old immigration law to ramp up deportations of undocumented migrants amid signs of frustration within the administration over the pace of efforts to ...

We ended up getting lucky with SARS. The coronavirus that caused it turned out to be far less infectious than it first ...